← Back to Blog

Does Lion's Mane Reduce Inflammation? What the Research Shows

Lion's mane is better known as a brain-health supplement, but its bioactive compounds show meaningful anti-inflammatory activity in laboratory models. The science on what this means for people taking it as a capsule is still catching up.

Written by Sydney Murphy, CMO & Digital Products Officer. Reviewed by the Sensa Wellness editorial team. Written to reflect current, publicly available inflammation research.

The short answer

Yes, in laboratory and animal models, lion's mane (Hericium erinaceus) consistently reduces pro-inflammatory cytokines and blocks key inflammatory signaling pathways such as NF-kB and JAK/STAT. Its bioactive polysaccharides and compounds like ergosterol appear to be the primary drivers of this effect. Human clinical trial data on inflammation markers specifically is still limited, so the precise real-world effect in healthy adults is not yet well characterized, but the mechanistic evidence is solid and the mushroom has a strong safety record in published trials.

Lion's mane has earned a following largely because of its neuroprotective properties. The compounds hericenones and erinacines, found in its fruiting body and mycelium, stimulate nerve growth factor synthesis, and the mushroom has been studied in human trials for mild cognitive impairment. What gets discussed less often is that the same organism also carries a range of bioactive molecules with documented anti-inflammatory activity. Understanding that dimension requires separating what cell culture and animal experiments show from what human clinical research has confirmed, and being honest about the gap between the two.

Hericium erinaceus (lion's mane) is an edible and medicinal mushroom native to North America, Europe, and Asia. It contains several classes of bioactive compounds, including beta-glucan polysaccharides, hericenones, erinacines, and ergosterol, that influence nerve growth, immune function, and inflammatory signaling.

What Makes Lion's Mane Biologically Active

Lion's mane is not a chemically simple food; it is a complex source of bioactive compounds, and different fractions of the mushroom appear to do different things. The polysaccharides, particularly the beta-glucans, are the main drivers of its immune-modulating and anti-inflammatory properties. These long-chain sugars interact with pattern recognition receptors on immune cells, influencing how those cells respond to inflammatory stimuli. The ethyl acetate fraction, which captures more lipophilic compounds, also carries anti-inflammatory activity. And then there is ergosterol, a sterol found in fungal cell membranes that has been shown to interact directly with bacterial lipopolysaccharide (LPS) in ways that blunt the inflammatory response.

The extraction method matters more than many supplement consumers realize. A hot water extract, an ethanol extract, and a full-spectrum powdered fruiting body each contain a different profile of active compounds. Studies published in 2022 and 2025 specifically investigated how extraction solvent changes the anti-inflammatory fingerprint of lion's mane. Research from Tohoku University found that an ethanol extract of H. erinaceus attenuated the production of IL-1beta, IL-6, and IL-8 in LPS-stimulated human monocytes, and that ergosterol was responsible for a significant portion of that effect by binding to lipid A and neutralizing LPS before it could trigger a full inflammatory cascade (Tada et al., 2022). A hot water extract tested in macrophages showed a partly different mechanism, working through the JAK1/STAT3 pathway to reduce IL-1beta, IL-6, and TNF-alpha (Ha et al., 2025). This means the form of lion's mane you take likely influences which pathways get modulated.

The Inflammatory Pathways Lion's Mane Targets

The clearest mechanistic picture from the laboratory literature points to NF-kB as a central target. Nuclear factor kappa B is sometimes called the master switch of inflammation, a transcription factor that, once activated, turns on dozens of genes encoding pro-inflammatory cytokines, adhesion molecules, and enzymes like COX-2 and inducible nitric oxide synthase (iNOS). Research examining H. erinaceus extract in human endothelial cells found that the mushroom suppressed TNF-alpha-induced activation of NF-kB, blocked matrix metalloproteinase-9 (MMP-9) activity, and simultaneously activated Nrf2, the transcription factor that upregulates the body's endogenous antioxidant defenses. The researchers described the net effect as a shift from an inflammatory, pro-angiogenic cell state toward an antioxidant, protective one (Chang et al., 2016).

Beyond NF-kB, the JAK1/STAT3 axis has emerged as a second well-documented target. The JAK/STAT pathway is how many cytokines transmit their signals into cells. When IL-6 binds to its receptor, for example, it triggers JAK1 phosphorylation, which activates STAT3, which then moves into the nucleus and drives more inflammatory gene expression. The 2025 study by Ha and colleagues at Yonsei University showed that a hot water extract of H. erinaceus blocked both JAK1 and STAT3 phosphorylation in LPS-stimulated macrophages, reducing not just the cytokines IL-1beta, IL-6, and TNF-alpha but also increasing the anti-inflammatory cytokine IL-10 (Ha et al., 2025). An increase in IL-10 matters: this cytokine acts as a natural brake on inflammation, and its elevation suggests lion's mane is not simply suppressing one pathway but helping to rebalance the pro- and anti-inflammatory signaling.

A third target is JNK, a kinase involved in adipose tissue inflammation. Research published in the International Journal of Medicinal Mushrooms examined whether lion's mane could address the low-grade inflammation that develops in fat tissue during obesity. Using a coculture system of fat cells and macrophages, the authors found that the ethyl acetate fraction of H. erinaceus suppressed TNF-alpha and IL-6 in macrophages, inhibited JNK activation in those cells, and also reduced the inflammatory cytokine burden on the fat cells themselves, partly by preserving adiponectin, an anti-inflammatory hormone that fat tissue normally produces (Mori et al., 2015). The TLR4/JNK signaling axis is one of the pathways through which excess fat mass drives systemic inflammatory tone, and finding that lion's mane interferes with it in a relevant cellular model is meaningful context for why the mushroom might have systemic relevance.

Gut Inflammation and the Microbiome

One of the more compelling lines of animal research on lion's mane and inflammation involves the gut. Inflammatory bowel conditions involve chronic, dysregulated immune activation in intestinal tissue, driven partly by a disrupted relationship between gut bacteria and the mucosal immune system. A study published in the Journal of Nutritional Biochemistry tested the polysaccharide fraction of H. erinaceus (HECP) in mice with chemically induced colitis and found it improved clinical symptoms, lowered markers of oxidative stress, suppressed NF-kB and MAPK signaling in colon tissue, and partially reversed the gut microbiota changes associated with colitis (Ren et al., 2018). Notably, one of the bacterial genera that the lion's mane polysaccharide helped restore was Akkermansia, a commensal organism associated with a healthy gut barrier and reduced metabolic inflammation.

Animal colitis models also show that an ethanol extract of lion's mane reduces colon inflammation through multiple mechanisms simultaneously. Research published in the International Journal of Medicinal Mushrooms found that oral administration of H. erinaceus extract reduced myeloperoxidase accumulation in colon tissue, which is a direct indicator of neutrophil-driven inflammation, while also lowering TNF-alpha, IL-1beta, and IL-6 and reducing oxidative stress markers in blood (Qin et al., 2016). These findings are consistent across multiple independent research groups, which strengthens the basic biological case that lion's mane has real anti-inflammatory activity in the gut specifically.

The gut connection matters for general wellness because intestinal inflammation is not just a problem for people with diagnosed bowel conditions. Low-grade intestinal permeability and dysbiosis are increasingly recognized as contributors to systemic inflammatory tone, and anything that supports mucosal integrity and a diverse, balanced microbiome has the potential to lower baseline inflammation across the whole body. Lion's mane appears to work on this dimension in multiple ways at once, through its direct anti-inflammatory effects on mucosal immune cells and through the prebiotic-like effects its polysaccharides may exert on beneficial gut bacteria.

Human Research and What It Does and Does Not Show

The honest summary of human trial data on lion's mane and inflammation is that it is thin but not absent. Most published human trials have used the mushroom for cognitive or psychological outcomes rather than inflammatory markers. A double-blind, placebo-controlled trial of 30 participants diagnosed with mild cognitive impairment found that daily H. erinaceus supplementation for 16 weeks significantly improved scores on a cognitive function scale compared with placebo, with no adverse effects (Mori et al., 2009). A separate randomized trial in women found that four weeks of H. erinaceus intake reduced depression and anxiety scores on validated scales (Nagano et al., 2010). Neither trial measured CRP or other inflammatory markers, so they do not directly confirm the anti-inflammatory mechanism at work in humans.

A comprehensive 2020 review in the journal Nutrients examined preclinical and clinical findings across lion's mane and two related medicinal mushrooms. The authors concluded that H. erinaceus reduces pro-inflammatory cytokines, modulates oxidative stress, and shifts gut microbiota composition in directions associated with lower inflammation, though they noted that the clinical evidence in humans was primarily for cognitive and immune outcomes rather than for inflammatory marker changes specifically (Hetland et al., 2020). The safety picture from that review was reassuring: no serious adverse effects have been reported across published human trials, and the mushroom appears well tolerated at typical supplemental doses.

The implication for a person considering lion's mane is straightforward. The laboratory evidence for anti-inflammatory activity is strong and mechanistically plausible. The human evidence on inflammatory endpoints specifically is not yet there in the same way it is for, say, omega-3s or curcumin. That does not mean the supplement does not work in humans; it means we have more mechanistic data than outcome data at this point, and that is a distinction worth making. For someone interested in potential anti-inflammatory support alongside a broader lifestyle approach, lion's mane has a reasonable evidence base and a good safety record. For someone expecting a dramatic reduction in their CRP level based on taking a lion's mane capsule, the clinical trial literature does not yet support that specific expectation.

How to Use Lion's Mane Sensibly

Dosing in human trials has generally used whole mushroom powder at around 500 mg to 3 grams per day in divided doses, taken with food. Commercially available capsules typically provide 500 mg to 1,000 mg per serving of either fruiting body powder or mycelium extract, and products vary considerably in their beta-glucan content and extraction method. Because the anti-inflammatory fractions differ between hot water extracts and ethanol extracts, a dual-extraction product that captures both water-soluble and alcohol-soluble compounds gives you the broadest spectrum of the bioactives studied in the literature.

Lion's mane is considered safe for most people, but a few cautions apply. People with mushroom allergies should approach it carefully, as contact dermatitis has been reported in some cases. Individuals on anticoagulant or antiplatelet medications should discuss it with a healthcare provider, since some animal research suggests H. erinaceus may influence platelet aggregation. Pregnant or breastfeeding women are advised to consult their provider before supplementing, since human safety data for those populations is limited.

As with any single supplement, the realistic contribution of lion's mane to inflammatory control is modest compared with the fundamentals. Sleep quality, physical activity, body composition, the ratio of whole foods to ultra-processed foods in your diet, and chronic stress levels all exert larger and better-documented effects on CRP and other inflammatory markers than any single mushroom supplement is likely to match. Lion's mane fits naturally into an anti-inflammatory lifestyle approach as a complement to those fundamentals, not a replacement for them. And because CRP reflects the net output of everything affecting inflammation in your body at once, tracking it over time is the most reliable way to see whether any change you make is actually moving the needle. That includes dietary additions like lion's mane as well as the larger lifestyle levers you are pulling simultaneously. CRP is a general wellness marker rather than a diagnosis, and any persistent elevation is worth discussing with a healthcare provider.

Sources

  • Hetland G, Tangen JM, Mahmood F, et al. Antitumor, Anti-Inflammatory and Antiallergic Effects of Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies. Nutrients, 2020. pubmed.ncbi.nlm.nih.gov/32397163
  • Ha SO, Yu SE, Park SE, et al. Anti-inflammatory effects of Hericium erinaceus hot water extract via the JAK1/STAT3 pathway in LPS-stimulated RAW 264.7 macrophages. BMB Reports, 2025. pubmed.ncbi.nlm.nih.gov/41168894
  • Tada H, Kawahara K, Osawa H, et al. Hericium erinaceus ethanol extract and ergosterol exert anti-inflammatory activities by neutralizing lipopolysaccharide-induced pro-inflammatory cytokine production in human monocytes. Biochemical and Biophysical Research Communications, 2022. pubmed.ncbi.nlm.nih.gov/36335857
  • Ren Y, Geng Y, Du Y, et al. Polysaccharide of Hericium erinaceus attenuates colitis in C57BL/6 mice via regulation of oxidative stress, inflammation-related signaling pathways and modulating the composition of the gut microbiota. Journal of Nutritional Biochemistry, 2018. pubmed.ncbi.nlm.nih.gov/29677563
  • Chang HC, Yang HL, Pan JH, et al. Hericium erinaceus Inhibits TNF-alpha-Induced Angiogenesis and ROS Generation through Suppression of MMP-9/NF-kB Signaling and Activation of Nrf2-Mediated Antioxidant Genes in Human EA.hy926 Endothelial Cells. Oxidative Medicine and Cellular Longevity, 2016. pubmed.ncbi.nlm.nih.gov/26823953
Share this article

Frequently Asked Questions

Does lion's mane reduce inflammation?

In cell culture and animal studies, yes. Lion's mane contains bioactive compounds including beta-glucan polysaccharides and ergosterol that consistently suppress pro-inflammatory cytokines such as TNF-alpha, IL-1beta, and IL-6, and block key signaling pathways including NF-kB and JAK1/STAT3. Human clinical trials have not yet directly measured CRP or other inflammatory markers, so the precise effect in people taking a supplement daily is not yet well characterized.

What compounds in lion's mane are anti-inflammatory?

The main anti-inflammatory fractions are the beta-glucan polysaccharides and the ethanol-soluble compounds including ergosterol. Polysaccharides appear to modulate immune cell behavior and support gut barrier integrity, while ergosterol has been shown to bind bacterial lipopolysaccharide and blunt the inflammatory response it would otherwise trigger. The extraction method used to make a supplement determines which of these fractions are present.

How does lion's mane compare to other anti-inflammatory supplements?

Compared with supplements like fish oil or curcumin, lion's mane has stronger mechanistic laboratory evidence and a good safety record but less human clinical data on inflammatory markers specifically. It is best viewed as a complement to lifestyle fundamentals like sleep, exercise, and diet rather than a first-line or standalone anti-inflammatory intervention.

Is lion's mane safe to take?

Published human trials have reported no serious adverse effects. People with mushroom allergies should use caution, and those on anticoagulant medications or who are pregnant or breastfeeding should discuss it with a healthcare provider before supplementing. Typical supplemental doses range from 500 mg to 3 grams of fruiting body powder or extract per day.

Want to track your inflammation as part of a healthy lifestyle?

Sensa is a general wellness tool that lets you measure your CRP levels at home. No needles, no clinic visit. Track trends over time and make more informed lifestyle choices.

Buy Now

Get inflammation insights in your inbox

New articles on inflammation science, plus updates on the Sensa at-home CRP test and app.